NGS Propels Personalized Oncology
Oncology has risen to the forefront of genomic profiling, which is being used to identify actionable driver mutations and other markers. These markers can...
Owlstone Medical to Fund Global Commercialization with $50M Financing
New funding will allow for the global commercialization of the company's Breath Biopsy technology which measures volatile organic compounds
Adaptive Immune System Analysis at Single-Cell Resolution
The new Chromium™ Single Cell V(D)J Solution allows the profiling of paired V(D)J transcripts from hundreds to millions of lymphocytes.
Sanford Health to Power Genomic Cancer Care at Ireland’s Hermitage Medical
The program at Hermitage Medical Center is part of Sanford World Clinic which seeks to bring genomic cancer care to patients worldwide
Vaping Tied to DNA Damage
Researchers say vapers have higher levels of some DNA-damaging compounds in their saliva, and DNA damage consistent with those compounds
Complex Genetics Underpin Treatment Resistance to NSCLC
Mutations can frequently vary between biopsies, with 19% of patients harboring more than one type of genetic resistance to treatment.
![A study found that whole exome sequencing holds promise for providing information and management options for patients and their families dealing with complex genetic conditions. [iStock/Adventtr]](https://www.clinicalomics.com/wp-content/uploads/2019/01/453-218x150.jpeg "Whole Exome Sequencing Wins Blue Ribbon")
Whole Exome Sequencing Wins Blue Ribbon
GeneDx’ subsidiary BioReference Laboratories published results in Genetics in Medicine from a retrospective review of molecular diagnostic testing by whole exome sequencing (WES). According...
![New efforts toward improved prostate cancer screening have uncovered a multitude of new genetic variants that could help to identify men who have a substantially higher chance of developing the disease. [iStock/dra_schwartz]](https://www.clinicalomics.com/wp-content/uploads/2019/01/449-218x150.jpeg "Case Study: Prostate Cancer: A Closer Look at Risk Factors")
Case Study: Prostate Cancer: A Closer Look at Risk Factors
Prostate cancer is a relatively common disease with high morbidity and mortality; it is expected to kill more than 27,000 men this year in...
Metabolon to Profile Samples of Million Veteran Program Participants
Company will use its Precision Metabolomics technology to analyze samples, with the aim of identifying biomarkers of wellness and disease
Sophia Genetics Granted CE-IVD Mark for Leukemia Genomic Test
The company says its test is the first capture-based myeloid genomic test to receive a CE-IVD mark
